Latest Conference Articles

Formulary management tools can seem daunting or frustrating, but are ultimately effective ways to control costs without compromising clinical outcomes.

In a session at the American Society of Hematology Annual Meeting and Exposition, held December 7-10 in Orlando, Florida, experts presented on the evolution of CLL therapy, how to make treatment decisions, and what’s to come in the future based on ongoing studies.

Population migration to more urban locales, and rural hospital closures are some factors increasing the challenges of health care access to patients and pharmacists in remote areas of the country. Innovation advocated by the National Rural Health Association (NRHA) may provide keys to improving access to health care services.

Jennifer Woyach, MD, associate professor at The Ohio State University, gives an overview of the new data in chronic lymphocytic leukemia being presented at the 2019 American Society of Hematology Annual Meeting and Exposition.

Jennifer Woyach, MD, associate professor at The Ohio State University, discusses current clinical trials going on in the chronic lymphocytic leukemia space that are most likely to impact the treatment landscape.

Jennifer Woyach, MD, associate professor at The Ohio State University, explains how patient-specific factors can help determine treatment decisions in chronic lymphocytic leukemia.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, CEO of Remitigate, discusses how opioid and pain management guidelines have evolved. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.

The study evaluated lymphoma characteristics and outcomes in hepatitis C virus-associated B-cell non-Hodgkin lymphoma in African American patients.

A novel, off-the-shelf bispecific antibody could serve as a new treatment option for patients with non-Hodgkin lymphoma who don’t respond to CAR T-cell therapy.

A study looked at adherence rates and potential predictors of nonadherence in patients with hemophilia receiving emicizumab.

The analysis evaluated emerging mutations in patients with relapsed/refractory acute myeloid leukemia receiving gilteritinib therapy in the phase 3 ADMIRAL study.

A prospective analysis of the CLL14 trial showed that fixed-duration treatment of venetoclax plus obinutuzumab achieved high rates of undetectable minimal residual disease.

Patients receiving novel oral therapeutics often have a high dependence on financial assistance; specialty pharmacies may help facilitate access to these therapies.

Pharmacy Times® will be on site at the 61st American Society of Hematology Annual Meeting and Exposition.

The educational sessions are available live and via simulcast.

Specialty Pharmacy Times will be on-site in San Antonio, TX, for the 2019 San Antonio Breast Cancer Symposium, taking place December 10 to 14, 2019.

Amina Abubakar, PharmD, AAHIVP, discusses the current regulatory system around pharmacogenomics. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Amina Abubakar, PharmD, AAHIVP, discusses how pharmacogenomics works in her daily practice with patients. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Calvin Knowlton, BSc Pharm, MDiv, PhD, and CEO, Chairman, & Founder of Tabula Rasa Healthcare, discusses his model for the 'concierge pharmacist' and what it means for pharmacy profits. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Ken Whittemore, VP of professional & regulatory affairs for SureScripts, discusses how SCRIPT standards began. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Jesica Mills, PharmD, MBA, discusses the opportunities pharmacists have to help their patients with hemp-derived CBD products. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Kala Shankle, JD, and Lisa Schwartz, PharmD, RPh, discuss the DSCSA and what it means for pharmacists. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Care planning can increase pharmacy profits through efficiencies and through new revenue from payers that value what pharmacists do for patients, if they see the documentation of what has been done.

Karla Palmer, director at Hyman, Phelps, & McNamara, discusses how the Hemp Farming Act of 2018 affected hemp and CBD products.

The National Community Pharmacists Association Foundation honored Sharon M. Sherrer, PharmD, during the NCPA 2019 Annual Convention in San Diego, California

Calvin Knowlton, BSc Pharm, MDiv, PhD, and CEO, Chairman, & Founder of Tabula Rasa Healthcare, discusses how pharmacists should approach adverse drug events and reactions to better help their patients.

Ghada Abukuwaik, RPh, of Curemed Pharmacy in Clifton, NJ, was awarded the 2019 NCPA Innovation Center Outstanding Adherence Practitioner Award in recognition of her commitment to improving medication adherence. The award is sponsored by RxSafe and was presented at the National Community Pharmacists Association’s 2019 Annual Convention in San Diego.

At the ESMO Congress 2019, Eileen O'Reilly, MD, from Memorial Sloan Kettering Cancer Center, discussed the common themes among emerging therapies in the advanced pancreatic cancer setting.

Two experts shared best practices for operating a pharmacy convenience packaging service with attendees of the National Community Pharmacists Association (NCPA) 2019 Annual Convention in San Diego, California, on Sunday, October 27.

Making medication synchronization a core tenet of a pharmacy’s business can lead to success.